DOCMF
Dr. Martens plc
Set alert
- YTD
- -17.48%
- 1 year
- -31.45%
- Open
- 0.9266
- Prev close
- 0.85
- Mkt cap
- 813.59M
- Vol
- 100
- Avg vol
- 5.52K
- EPS
- 0.03
- P/E
- 28.33
More statistics
- Low
- 0.9266
- High
- 0.9266
News
5 months ago seekingalpha.com
Dr. Martens plc (DRMTY) Q4 2026 Earnings Call Transcript
Dr. Martens plc (DRMTY) Q4 2026 Earnings Call Transcript
5 months ago proactiveinvestors.co.uk
Dr Martens profits jump as turnaround gains grip
Dr Martens PLC (LSE:DOCS) returned to profit growth last year as the bootmaker tightened discounting, improved margins and pushed ahead with a turnaround centred on higher-quality sales. The FTSE…
9 months ago seekingalpha.com
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
9 months ago wsj.com
Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness
Chief Executive Ije Nwokorie said the EMEA market continued to be challenging, and that the company had taken a more disciplined promotional stance there.
9 months ago proactiveinvestors.co.uk
Dr Martens sales growth slows but 'significant' profit increase still expected
Dr Martens PLC (LSE:DOCS) reported a decline in sales in the past quarter but said it is still on track to deliver "significant profit growth" in the current financial year. Revenues fell 3.1% to…
11 months ago seekingalpha.com
Dr. Martens plc (DRMTY) Q2 2026 Earnings Call Transcript
Dr. Martens plc (OTCPK:DRMTY) Q2 2026 Earnings Call November 20, 2025 4:30 AM EST Company Participants Ije Nwokorie Giles Wilson - CFO & Director Conference Call Participants John Stevenson - Peel…
11 months ago proactiveinvestors.co.uk
Dr Martens drops despite results in line with forecasts
Dr Martens PLC (LSE:DOCS) shares stomped almost 7% lower to 76p after the bootmaker reported first half results in line with market expectations, saying it expects to offset the full-year effect of…
1 year ago proactiveinvestors.co.uk
Dr Martens back on its feet
It has been a tough couple of years for Dr Martens PLC (LSE:DOCS), but Berenberg thinks the bootmaker is lacing up for recovery. The broker keeps its 'buy' rating and 114p price target, saying the…
1 year ago proactiveinvestors.co.uk
Dr Martens tiptoes higher after positive America retail trading, UK still challenging
Dr Martens PLC (LSE:DOCS) said trading since the start of the financial year has been in line with expectations, with guidance for its current financial year unchanged and profit expected to be…
1 year ago seekingalpha.com
Dr. Martens: Iconic Brand At A Potential Bargain
Dr. Martens remains profitable despite recent challenges, with a strong brand moat and loyal customer base supporting its long-term investment case. Cost-cutting, improved inventory control, and a…
1 year ago proactiveinvestors.co.uk
Dr Martens surges 23% as investors lace up for recovery story
Shares in Dr Martens PLC (LSE:DOCS) jumped 23% on Thursday after the bootmaker delivered a better-than-expected full-year update and signalled a shift towards stabilisation and future growth, giving…
1 year ago seekingalpha.com
Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript
Dr. Martens plc (OTCPK:DOCMF) Q4 2025 Earnings Conference Call June 5, 2025 2:00 AM ET Company Participants Giles Wilson - CFO & Director Onyeije Ogueri Nwokorie - CEO & Chief Brand Officer Onyeije…
1 year ago proactiveinvestors.co.uk
Dr Martens marketing 'reset' saw annual revenue and profit retreat, eyes return to growth this year
Dr Martens PLC (LSE:DOCS) reported a 10% drop in group revenue to £787.6 million for the year ended 30 March 2025, amidst a marketing 'reset'. Adjusted profit before tax fell to £34.1 million from…
1 year ago proactiveinvestors.co.uk
Dr Martens interims a first test for new CEO after shares stumble to all-time low
Dr Martens PLC (LSE:DOCS) shares stumbled to a new all-time low below 50p last month after the US tariff announcement, but have been tiptoeing higher in the run-up to interim results due next…
1 year ago businesswire.com
Dr. Martens Selects Amperity to Transform Customer Data Strategy
LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and…
1 year ago seekingalpha.com
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript
Dr. Martens plc (OTCPK:DOCMF) Q3 2025 Sales/ Trading Statement Call January 27, 2025 4:00 AM ET Company Participants Ije Nwokorie - CEO Giles Wilson - CFO Conference Call Participants Kate Calvert -…
1 year ago proactiveinvestors.co.uk
Dr Martens flags ‘progress' as constant currency revenue grows
Dr Martens PLC has flagged “good progress” in its turnaround after revenue ticked up on a constant currency basis during the third quarter. Group revenue climbed by 3% to £267 million, aided by…
1 year ago proactiveinvestors.co.uk
Dr Martens and Ryanair in focus on Monday
Updates from Dr Martens and Ryanair on Monday will kick off next week's proceedings.
1 year ago proactiveinvestors.co.uk
Dr Martens recovery plan to be tested in forthcoming update
Dr Martens PLC (LSE:DOCS) shares have been rising recently, a rare event since the iconic boot maker listed in 2021. New chief executive Ije Nwokorie, ex-Wolff Olins and Apple, came with a lot of…
1 year ago proactiveinvestors.co.uk
Dr Martens redemption arc will be ‘multi-year event'
The post-IPO narrative surrounding footwear icon Dr Martens PLC (LSE:DOCS) has been so overwhelmingly negative that it's easy to glance over the green shoots of optimism emerging from the business.…
-
3 years ago benzinga.com
This Week: JPMorgan, Pepsi, Delta Air Lines, ConAgra Among Companies To Report Earnings
Another quarterly earnings season is about to kick off.